Search control section

The MyHospitals website is moving on 31 March 2020

Don’t worry – from December 11 2019 you will be able to find the latest information about your local area on the MyHospitals webpages on the AIHW website, along with many more reports and data on a range of health and welfare topics.

In some cases, the way you find information has changed. If you need help finding anything, please contact the AIHW.

Once the new MyHospitals website has been created, you will be able to access old archived versions of the previously published data through Trove, the National Library of Australia’s web archive. Please note the interactive content will not work in the archived version.

Fewer than 50 beds
This is a public hospital

Caloundra Hospital

Left hand navigation section

Safety & quality

Healthcare-associated infections

Staphylococcus aureus (S. aureus or ‘Golden staph’) is a type of bacterium that can cause an infection of the bloodstream and can be acquired after a patient receives medical care or treatment in hospital. Contracting an S. aureus bloodstream infection while in hospital can be life-threatening. Hospitals aim to have as few cases as possible.

The data presented below show S. aureus bloodstream infections that were found to have been acquired while receiving care at this hospital.

All healthcare-associated S. aureus bloodstream infections

In 2017–18, there were 0 cases reported during 7,879 days of patient care under surveillance at this hospital. The rate of infection was 0.00 cases per 10,000 days of patient care under surveillance, compared to this hospital's national peer group performance of 0.55.

Year Cases Rate Peer group average Patient days under surveillance
NA Data for this hospital were not available in this time period.
2017–18 0 0.00 0.55 7,879
2016–17 0 0.00 0.49 30,650
2015–16 0 0.00 0.51 36,454
2014–15 0 0.00 0.42 32,844
2013–14 0 0.00 0.47 30,707
2012–13 1 0.33 0.63 30,769
2011–12 3 0.96 0.50 31,260
2010–11 NA NA 0.68 NA

NA Data for this hospital were not available in this time period.

Healthcare-associated methicillin-resistant S. aureus (MRSA) bloodstream infections

An S. aureus bloodstream infection that is identified by a laboratory as being caused by methicillin-resistant S. aureus (MRSA) may cause more harm to patients and is associated with poorer outcomes as there are fewer antibiotics available to treat the infection.

In 2017–18, there were 0 cases of MRSA reported during 7,879 days of patient care under surveillance at this hospital. The rate of infection was 0.00 cases per 10,000 days of patient care under surveillance, compared to this hospital's national peer group performance of 0.11.

Year Cases Rate Peer group average Patient days under surveillance
2017–18 0 0.00 0.11 7,879
2016–17 0 0.00 0.08 30,650

Healthcare-associated methicillin-sensitive S. aureus (MSSA) bloodstream infections

An S. aureus bloodstream infection that is identified by a laboratory as being caused by methicillin-sensitive S. aureus is referred to as MSSA.

In 2017–18, there were 0 cases of MSSA reported during 7,879 days of patient care under surveillance at this hospital. The rate of infection was 0.00 cases per 10,000 days of patient care under surveillance, compared to this hospital's national peer group performance of 0.44.

Year Cases Rate Peer group average Patient days under surveillance
2017–18 0 0.00 0.44 7,879
2016–17 0 0.00 0.42 30,650